Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.7500
-0.0250 (-3.23%)
Sep 29, 2025, 4:35 PM GMT+1
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 20.90 million as of September 29, 2025. Its market cap has increased by 353.51% in one year.
Market Cap
20.90M
Enterprise Value
19.58M
Revenue
1.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.75
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 20.90M, a decrease of -78.57%. That is a compound annual growth rate of -33.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 20.90M | 194.17% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.58B |
| GSK plc | 59.81B |
| Haleon | 29.47B |
| Smith & Nephew | 11.43B |
| ConvaTec Group | 4.54B |
| Hikma Pharmaceuticals | 3.64B |
| HUTCHMED (China) | 2.02B |
| Genus | 1.52B |